Briefing: STAT+: As controversial decisions mount, FDA shuns public advisory meetings
Strategic angle: The FDA is cutting back on public advisory committee meetings, even as the public and other stakeholders seek more transparency.
Browse the full archive, newest first.
Strategic angle: The FDA is cutting back on public advisory committee meetings, even as the public and other stakeholders seek more transparency.
Strategic angle: Trump's aggressive push toward deep-sea mining is putting pressure on global negotiators to act fast to shape deep-sea mining rules.
Smackover Lithium secures its first binding customer offtake agreement, marking a significant milestone for the South West Arkansas Project.
Strategic angle: Iraq head coach Graham Arnold advocates for rescheduling the World Cup play-off to enhance his team's chances of qualifying.
Strategic angle: The conflict between the US and Iran keeps unfolding, with thousands of Iranian casualties and escalating fighting across the Middle East.